BDNF and depressive symptom measurement: Neuronal activation in the IL by using a chemogenetic tool reversed the depression- and anxiety-like phenotypes induced by estradiol withdrawal and induced accordingly the upregulation of BDNF/β-catenin in the IL and BLA.